MEngSc Biopharmaceutical Engineering

Graduate Taught (level 9 nfq, credits 90)

Excellent employment record
This programme has an excellent employment record. Results in an internationally recognised graduate qualification that provides graduates with the knowledge and skills required to gain high level professional jobs in the biopharmaceutical and pharmaceutical sector.

Facilities and Resources
This programme is closely linked with the NIBRT facility. NIBRT offers a quality training and research experience not previously possible anywhere in the world. At the heart of the NIBRT building is the bioprocessing pilot plant, consisting of extensive upstream, downstream, fill-finish and the associated analytical facilities. These facilities are all operated in a realistic GMP simulated, operational manufacturing environment.  

Full Time option suitable for:

Domestic(EEA) applicants: Yes
International (Non EEA) applicants currently residing outside of the EEA Region. Yes

Part Time option suitable for:

Domestic(EEA) applicants: Yes
International (Non EEA) applicants currently residing outside of the EEA Region. No

Your career opportunities upon graduation from this programme are exemplary. Ireland is a world player in pharmaceutical and biopharmaceutical production.

The pharmaceutical industry in Ireland comprises a mix of international and local companies. Approximately, 120 overseas companies have plants in Ireland, including many of largest pharmaceutical and biopharmaceutical companies in the world including Pfizer, GSK, Merck, AbbVie, Novartis, Jansen Biologics (Ireland), Biomarin, Roche, Sanofi Genzyme and many more. Upon graduation from this programme, you will enjoy an extremely high job placement rate with superlative career opportunities.

MEngSc Biopharmaceutical Engineering (T015) Part Time
EU          Year 1 - € 3790
EU          Year 2 - € 3790
EU          Year 3 - € 1840

MEngSc Biopharmaceutical Engineering (T070) Full Time
EU          fee per year - € 7200
nonEU    fee per year - € 22900

***Fees are subject to change
Tuition fee information is available on the UCD Fees website. Please note that UCD offers a number of graduate scholarships for full-time, self-funding international students, holding an offer of a place on a UCD graduate degree programme. For further information please see International Scholarships.

  • A 4-year bachelors degree with a minimum upper second class honours (NFQ level 8) or international equivalence in a relevant Engineering, Science or Technology programme.
  • Applicants whose first language is not English must also demonstrate English language proficiency of IELTS 6.5 (no band less than 6.0 in each element), or equivalent.

  • Graduate Profile
    Premchandran, India,
    Graduate


    The primary reason I chose the masters in Biopharmaceutical Engineering is to work in the field of drug discovery and development in relation to Diabetes Mellitus. I chose Ireland because it is a land of opportunities for biopharmaceuticals. The course work at UCD has strong emphasis on both research-oriented subjects as well as in the engineering field, which motivated me to choose the programme. Ireland is known for its top pharmaceutical and biopharmaceutical industry. When looking from a career point of view, it has huge opportunities for young talented graduates. Additionally, the one-year stay back visa grabbed my attention. What stood out for me on my UCD journey was the friendly interaction with the professors and the facilities at UCD in general were stupendous. I would definitely recommend my fellow Indians to choose this University for their higher education.

  • MEngSc Chemical Engineering
  • MSc Biotechnology

  • The following entry routes are available:

    MEngSc Biopharmaceutical Engineering FT (T070)
    Duration
    1 Years
    Attendance
    Full Time
    Deadline
    Rolling *
    MEngSc Biopharmaceutical Engineering PT (T015)
    Duration
    2 Years
    Attendance
    Part Time
    Deadline
    Rolling *

    * Courses will remain open until such time as all places have been filled, therefore early application is advised